SCHEMBL1016713

SCHEMBL1016713

CCN(CC)CC=CC(=O)N1CCc2c(sc3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.67
MKNK1 Q9BUB5 2/20 0.50
ERBB2 P04626 5/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016711 1.00 EGFR (0.67) EGFRMKNK1ERBB2
SCHEMBL1017039 0.95 EGFR (0.68) EGFRMKNK1ERBB2
SCHEMBL1017041 0.95 EGFR (0.68) EGFRMKNK1ERBB2
SCHEMBL3616602 0.94 EGFR (0.70) EGFRMKNK1ERBB2
SCHEMBL1017735 0.93 EGFR (0.60) EGFRERBB2
SCHEMBL1017734 0.93 EGFR (0.60) EGFRERBB2
SCHEMBL1015556 0.92 EGFR (0.80) EGFRMKNK1ERBB2
SCHEMBL1016383 0.92 EGFR (0.68) EGFRMKNK1ERBB2
SCHEMBL1016382 0.92 EGFR (0.68) EGFRMKNK1ERBB2
SCHEMBL1015558 0.92 EGFR (0.80) EGFRMKNK1ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001890-B1 TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS BAYER SCHERING PHARMA AG (DE) 2011-01-12 EP disclosed